DNA GINKGO BIOWORKS HOLDINGS INC
FollowCOMMON STOCK (common), issuer CIK 1830214
Filings received so far for Q3 2026: 3 13F filers report a position in DNA shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Coen Steven P.officer (See remarks) | 2026-10-05 | -2,403 S | $15 | Form 4 |
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Boston Standard Wealth Management, LLC | 15,165 | $195K | 0.03% | 0 | 13F-HRTimeline |
| GAMMA Investing LLC | 1,338 | $17.2K | <0.01% | +300 | 13F-HRTimeline |
| Farther Finance Advisors, LLC | 489 | $6.27K | <0.01% | -119 | 13F-HRTimeline |
Events
Coen Steven P. sold 2,403 DNA shares on 2026-10-05, Form 4 filed 2026-10-07. 0001628280-26-065349
Accepted , ingested